Halda Therapeutics
$3.0B
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Halda Therapeutics is currently valued at $3.0B as of November 17, 2025. The company has raised a total of $227.1M in funding.
Capital Efficiency
With a capital efficiency ratio of 13.43x, Halda Therapeutics has achieved a valuation that is 13.43 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Halda Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Halda Therapeutics Worth in 2025?
As of 2025, Halda Therapeutics is valued at $3.0B, based on the company's Merger/Acquisition funding round in November 17, 2025. This valuation positions Halda Therapeutics as one of the leading private companies in the sector.
Halda Therapeutics Valuation History
Halda Therapeutics's funding history demonstrates steady growth and investor confidence.
How Halda Therapeutics Valuation is Determined
Private company valuations like Halda Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Halda Therapeutics Valuation FAQs
Is Halda Therapeutics profitable?
Halda Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Halda Therapeutics's valuation compare to competitors?
Halda Therapeutics is valued at $3.0B, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Halda Therapeutics IPO?
Halda Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Halda Therapeutics shares through secondary market platforms.